Connection

B Thompson to Risk Assessment

Back to Details
This is a "connection" page, showing publications B Thompson has written about Risk Assessment.
B Thompson
Connection Strength
0.014
Risk Assessment
  1. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019 02; 7(2):154-162.
    View in: PubMed
    Score: 0.009
  2. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med. 2011 Apr; 39(4):711-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.